Within the GBM microenvironment, CXCR4 facilitates the immunosuppressive and therapy-resistant phenotype of GBM by regulating SDF-1α (CXCL12)-mediated CD11b+ myeloid cell migration [70]. The gene discussed is ITGAM; the disease is glioblastoma.